Medicus Pharma Ltd.
Medicus Pharma Ltd.
- Market cap
- $2.58M
Your view on MDCXW
Overview
What the company does, where it operates, and who runs it.
About Medicus Pharma Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Raza Bokhari
- Headquarters
- 300 Conshohocken State Road, Conshohocken, PA, CA
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Raza Bokhari
- Headquarters
- 300 Conshohocken State Road, Conshohocken, PA, CA
Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Medicus Pharma Ltd.. Starting points for Medicus Pharma Ltd.: EPS -$33.76, beta -0.65 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Medicus Pharma Ltd.. Trailing twelve-month EPS for Medicus Pharma Ltd. stands at -$33.76. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$4.44 | −$0.23 | −$33.95 | −$15.15 |
| Lowest estimate | −$4.44 | −$0.23 | −$33.95 | −$15.15 |
| Highest estimate | −$4.44 | −$0.23 | −$33.95 | −$15.15 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | −$0.511 | −$0.311 | −$98.001 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $0.00 | $0.00 | $49440.00 | $0.00 |
| Lowest estimate | $0.00 | $0.00 | $49440.00 | $0.00 |
| Highest estimate | $0.00 | $0.00 | $49440.00 | $0.00 |
| Number of analysts | 0 | 0 | 4 | 0 |
| A year ago | $0.00 | $0.00 | $0.00 | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Medicus Pharma Ltd.. Medicus Pharma Ltd. has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| CUECue Biopharma, Inc. | Healthcare | Biotechnology | $34.7M | ||
| FBIOFortress Biotech, Inc. | Healthcare | Biotechnology | $63.4M | ||
| HOWLWerewolf Therapeutics, Inc. | Healthcare | Biotechnology | $46.0M | ||
| ICCCImmuCell Corporation | Healthcare | Biotechnology | $99.3M | ||
| INKTMiNK Therapeutics, Inc. | Healthcare | Biotechnology | $41.2M | ||
| NRXPNRx Pharmaceuticals, Inc. | Healthcare | Biotechnology | $95.3M | ||
| OSTXOS Therapies Incorporated | Healthcare | Biotechnology | $42.0M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BLAB.CNBritannia Life Sciences Inc. | Healthcare | CNQ | $13.0M | ||
| BLEGBranded Legacy Inc | Healthcare | OTC | $542,622 | ||
| BLRXBioLineRx Ltd. | Healthcare | NASDAQ | $4.8M | ||
| BLSMBlossomHill Therapeutics, Inc. | Healthcare | NASDAQ | $422.0M | ||
| BLTEBelite Bio, Inc | Healthcare | NASDAQ | $5.2B | ||
| BMEABiomea Fusion, Inc. | Healthcare | NASDAQ | $41.7M | ||
| BMNDFBiomind Labs Inc. | Healthcare | OTC | $8.8M | ||
| BMRNBioMarin Pharmaceutical Inc. | Healthcare | NASDAQ | $11.7B | ||
| BNIGFBeroni Group Limited | Healthcare | OTC | $220,063 | ||
| BNTCBenitec Biopharma Inc. | Healthcare | NASDAQ | $285.9M | ||
| BNTXBioNTech SE | Healthcare | NASDAQ | $20.1B | ||
| BOLDBoundless Bio, Inc. | Healthcare | NASDAQ | $54.8M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Medicus Pharma Ltd. executives and directors. Shares of Medicus Pharma Ltd. have traded between $0.44 and $2.50 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Medicus Pharma Ltd.